US Patent Issued to ASSOCIATION INSTITUT DE MYOLOGIE, INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE), SORBONNE UNIVERSITE on Dec. 16 for "Compositions for the treatment of sarcopenia or disuse atrophy" (French Inventors)

ALEXANDRIA, Va., Dec. 16 -- United States Patent no. 12,496,328, issued on Dec. 16, was assigned to ASSOCIATION INSTITUT DE MYOLOGIE (Paris), INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (Paris) and SORBONNE UNIVERSITE (Paris).

"Compositions for the treatment of sarcopenia or disuse atrophy" was invented by France Pietri-Rouxel (Clichy, France) and Sestina Falcone (Paris).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a substance that activates the GDF5 pathway, for use in a method for the treatment of age-related sarcopenia or disuse atrophy."

The patent was filed on July 19, 2019, under Application No. 17/261,314.

*For further information, including i...